Peak Bio, Inc. Warrant
PKBOW
PKBOW was delisted on the 5th of January, 2023.
14 hedge funds and large institutions have $1.19M invested in Peak Bio, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
50% more capital invested
Capital invested by funds: $795K → $1.19M (+$394K)
27% more funds holding
Funds holding: 11 → 14 (+3)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$328K |
| 2 |
DM
Deerfield Management
New York
|
+$288K |
| 3 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$15.9K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$12K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$8.99K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
-$60K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$29.8K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1K |
PKBOW Hedge Fund Activity: Q3 2021 in Review
14 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q3 2021, worth a combined $1.19M — up 50% from $795K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PKBOW positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was K2 Principal Fund, opening a new position worth an estimated $328K. The largest seller was Linden Advisors, exiting entirely with an estimated $60K sold.
- 14 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q3 2021, up from 11 in Q2 2021.
- Funds reported $1.19M of Peak Bio, Inc. Warrant stock for Q3 2021, up 50% quarter-over-quarter.
- 6 funds opened new Peak Bio, Inc. Warrant positions in Q3 2021 and 3 closed out, a net change of +3 holders.
- The largest Peak Bio, Inc. Warrant buyer in Q3 2021 was K2 Principal Fund, an estimated $328K added.
- The largest Peak Bio, Inc. Warrant seller in Q3 2021 was Linden Advisors, an estimated $60K sold.
Based on aggregated 13F filings for Q3 2021.